SG Americas Securities’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,753
Closed -$235K 3197
2017
Q3
$235K Hold
1,753
﹤0.01% 2451
2017
Q2
$220K Hold
1,753
﹤0.01% 2355
2017
Q1
$209K Sell
1,753
-22,039
-93% -$2.58M ﹤0.01% 2400
2016
Q4
$2.56M Sell
23,792
-2,226
-9% -$242K 0.02% 792
2016
Q3
$3M Buy
26,018
+21,977
+544% +$2.5M 0.03% 527
2016
Q2
$414K Sell
4,041
-21,925
-84% -$2.34M ﹤0.01% 1802
2016
Q1
$2.69M Buy
25,966
+21,550
+488% +$2.25M 0.02% 685
2015
Q4
$561K Buy
4,416
+2,800
+173% +$343K ﹤0.01% 1525
2015
Q3
$185K Sell
1,616
-6,591
-80% -$872K ﹤0.01% 1509
2015
Q2
$1.11M Sell
8,207
-6,100
-43% -$811K 0.01% 1033
2015
Q1
$1.85M Hold
14,307
0.01% 840
2014
Q4
$1.65M Sell
14,307
-4,420
-24% -$498K 0.01% 1032
2014
Q3
$1.98M Buy
18,727
+12,242
+189% +$1.24M 0.01% 882
2014
Q2
$619K Buy
+6,485
New +$581K ﹤0.01% 1594

Other funds holding BBH

SG Americas Securities's BBH Position: Q4 2017 in Review

SG Americas Securities sold out of VanEck Biotech ETF (BBH) in Q4 2017, closing a stake of 1,753 shares — an estimated $235K sold.

SG Americas Securities first reported a position in BBH in Q2 2014 and held it in 14 quarters. The position peaked at $3M in Q3 2016. 82 funds tracked by Wall St. Rank hold BBH as of Q4 2017.

  • SG Americas Securities reported no remaining VanEck Biotech ETF position as of Q4 2017 after selling out during the quarter.
  • SG Americas Securities sold 1,753 VanEck Biotech ETF shares in Q4 2017, an estimated $235K.
  • SG Americas Securities first reported a position in VanEck Biotech ETF in Q2 2014 and held it in 14 quarters.
  • SG Americas Securities's VanEck Biotech ETF position peaked at $3M in Q3 2016.
  • 82 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2017.

Based on SG Americas Securities's 13F filing for Q4 2017, filed 24 Jan 2018.